doi: 10.1007/BF01219645.
Plasma prolactin in juvenile diabetics. 24-h studies with somatostatin
- PMID: 570136
- DOI: 10.1007/BF01219645
Item in Clipboard
Plasma prolactin in juvenile diabetics. 24-h studies with somatostatin
Diabetologia.
1978 Nov.
Abstract
In normal subjects during 24-hours saline infusion, plasma prolactin showed a number of small rises during day and night. The mean night-time level was significantly higher than the day-time level (8.2 +/- 0.6 ng/ml as against 4.7 +/- 0.5 ng/ml). In 12 insulin-dependent diabetics the 24 h plasma prolactin pattern was identical to that found in normals. Somatostatin infusion (4 mg/24 h in normals; 2--6 mg/24 h in diabetics) had no effect on the 24 h plasma prolactin pattern in either normals or in diabetics.
Similar articles
-
24-hour studies of the effects of somatostatin on the levels of plasma growth hormone, glucagon, and glucose in normal subjects and juvenile diabetics.Diabetes. 1978 Mar;27(3):300-6. doi: 10.2337/diab.27.3.300. Diabetes. 1978. PMID: 640235
-
Somatostatin and the 24 h levels of serum TSH, T3, T4, and reverse T3 in normals, diabetics and patients treated for myxoedema.Acta Endocrinol (Copenh). 1980 May;94(1):30-7. doi: 10.1530/acta.0.0940030. Acta Endocrinol (Copenh). 1980. PMID: 6104408 No abstract available.
-
Absence of diurnal plasma prolactin rhythm in diabetic and non-diabetic uraemic patients.Acta Endocrinol (Copenh). 1984 Feb;105(2):173-8. doi: 10.1530/acta.0.1050173. Acta Endocrinol (Copenh). 1984. PMID: 6538055
-
Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.Biomed Pharmacother. 1986;40(2):61-4. Biomed Pharmacother. 1986. PMID: 2875745
-
[Increased plasma levels of prolactin].MMW Fortschr Med. 2021 Jul;163(13):55. doi: 10.1007/s15006-021-0083-5. MMW Fortschr Med. 2021. PMID: 34240376 Review. German. No abstract available.
Cited by
-
Study of pituitary secretion in relation to retinopathy in patients with juvenile diabetes mellitus.Acta Diabetol Lat. 1981 Oct-Dec;18(4):319-28. doi: 10.1007/BF02042815. Acta Diabetol Lat. 1981. PMID: 6277121
-
Effect of 4 weeks of octreotide treatment on prolactin, thyroid stimulating hormone and thyroid hormones in acromegalic patients. A double blind placebo-controlled cross-over study.J Endocrinol Invest. 1995 Dec;18(11):840-6. doi: 10.1007/BF03349830. J Endocrinol Invest. 1995. PMID: 8778155 Clinical Trial.
-
Drug-induced changes in prolactin secretion. Clinical implications.Med Toxicol Adverse Drug Exp. 1988 Nov-Dec;3(6):463-98. doi: 10.1007/BF03259897. Med Toxicol Adverse Drug Exp. 1988. PMID: 3063922 Review.